Dextrose Injection 50% Manufacturer

Product Overview

Sanjar Pharma manufactures Dextrose Injection 50% at its WHO-GMP compliant sterile injectable manufacturing facility. The product is manufactured using validated pharmaceutical processes, controlled production environments, and documented quality systems designed to support product consistency, sterility, and regulatory compliance.

Dextrose Injection 50% is part of the sterile injectable solutions category and is widely utilized in hospitals, healthcare institutions, emergency care environments, and pharmaceutical supply programs requiring high-quality injectable products. Manufacturing is supported by advanced analytical testing, microbiological monitoring, and quality assurance controls.

Supported by modern sterile manufacturing infrastructure and export-oriented pharmaceutical operations, Sanjar Pharma supplies Dextrose Injection 50% to pharmaceutical companies, healthcare institutions, procurement organizations, distributors, and international markets.